Caring Voice Coalition will reopen for grant applications on Monday January 16th at 9am Eastern time.  Patients who have yet to receive grant support should call and keep calling. You should also try and connect with Caring Voice by email and on their website. We have had encouraging news from several of the drug manufacturers that they are working with the federal … [Read more...]

2016 has been a busy year for PAH.  There was exciting progress and some disappointment as well.  Reata Pharmaceuticals launched their phase 3 study of Bardoxylone Methyl in connective tissue disease related PAH (The CATALYST Study) after showing promising results in their phase 2 study.  Actelion has started their phase 4 study (TRITON) comparing triple vs double up-front … [Read more...]

There is good news and bad news.  Let’s get the bad news out of the way first.  Good Days announced that they have no further funding available for 2017 for PAH patients.  Now the good news - Caring Voices announced that they will reopen their funding for 2017 beginning Thursday December 8th in the morning.  It is unclear how long they will remain open and how many patients … [Read more...]

We received notification today that Caring Voices has closed their 2017 roster of patients that they are able to help for the time being.  Very little guidance was given about what this means for the remainder of 2017.  There is a possibility that they will reopen their roster and be able to expand the number of PAH patients that they help. Unfortunately this has left … [Read more...]

The cost of Pulmonary Arterial Hypertension medications is staggering.  The least expensive medication  (generic sildenafil) costs $50 per month for 90 tablets.  If you prefer to have the branded version and you don’t have any insurance expect to pay more than $3,000 per month.  Insurance companies are very happy to pay for generic sildenafil but increasingly restrict Adcirca … [Read more...]